PRMT5 inhibitor (Sporos Bioventures/University of Texas MD Anderson Cancer Center)

N/A

Report date: 2025/06/11 10:22:32
NME

Base Information

Drug NamePRMT5 inhibitor (Sporos Bioventures/University of Texas MD Anderson Cancer Center)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionProtein arginine methyltransferase 5 inhibitors
TargetsProtein arginine methyltransferase 5
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesSporos Bioventures IncThe University Of Texas MD Anderson Cancer Center
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A